Bitfarms Seeks Shareholder Approval to Redomicile to U.S. and Rebrand as Keel Infrastructure
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Bitfarms ( (TSE:BITF) ).
Bitfarms has called on its shareholders of record as of February 13, 2026 to vote at a special meeting scheduled for March 20, 2026 on a plan to redomicile the company from Canada to the U.S. and rebrand as Keel Infrastructure. The board is unanimously backing the arrangement resolution, which requires approval by at least two‑thirds of votes cast, framing the move as a strategic pivot to become an infrastructure‑led developer of HPC and AI data centers across North America.
The most recent analyst rating on (TSE:BITF) stock is a Buy with a C$7.00 price target. To see the full list of analyst forecasts on Bitfarms stock, see the TSE:BITF Stock Forecast page.
Spark’s Take on TSE:BITF Stock
According to Spark, TipRanks’ AI Analyst, TSE:BITF is a Neutral.
Bitfarms’ overall score is primarily impacted by its financial performance, which is weighed down by consistent losses and negative cash flows. The earnings call provides a positive outlook with strategic initiatives, but technical analysis and valuation remain weak, reflecting ongoing challenges.
To see Spark’s full report on TSE:BITF stock, click here.
More about Bitfarms
Bitfarms Ltd. is a digital infrastructure company pivoting from its origins in cryptocurrency mining toward becoming an infrastructure‑first owner and developer of high‑performance computing and AI‑focused data centers. The company operates across North America and is seeking to reposition itself under the new brand Keel Infrastructure, with shares listed in both the U.S. and Canada.
Average Trading Volume: 4,704,523
Technical Sentiment Signal: Buy
Current Market Cap: C$1.72B
Learn more about BITF stock on TipRanks’ Stock Analysis page.
